Crescita Therapeutics Inc.
CTX.TO
Price:
$0.75
Market Cap:
$13.96M
Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. The company operates through three segments: Commercial Skincare, Licensing and Royalties, and Manufacturing and Services. It owns proprietary platform technologies, including MMPE and DuraPeel for the development of topicals containing cannabis and hemp. The company's prescription products include Pliaglis, a topical local anesthetic cream that provides dermal analgesia on intact skin prior to superficial dermatological procedures; CTX-101, a Phase III topical formulation utilizing a corticosteroid in combination wit...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2018-07-10
Stock Exchange
TSX
Ticker
CTX.TO
PE Ratio
[37.50]
ROE
[-0.59%]
Current Ratio
[3.33]
Dividend Yield
[0%]
Enterprise Value
[5.72M]
Dividend History
The ROE as of April 2026 (TTM) for Crescita Therapeutics Inc. (CTX.TO) is -0.59%
According to Crescita Therapeutics Inc.’s latest financial reports and current stock price. The company's current ROE is -0.59%. This represents a change of 116.72% compared to the average of -0.27% of the last 4 quarters.
Crescita Therapeutics Inc. (CTX.TO) Historical ROE (quarterly & annually)
How has CTX.TO ROE performed in the past?
The mean historical ROE of Crescita Therapeutics Inc. over the last ten years is -15.15%. The current -0.59% ROE has changed -96.10% with respect to the historical average. Over the past ten years (40 quarters), CTX.TO's ROE was at its highest in in the September 2020 quarter at 19.32%. The ROE was at its lowest in in the December 2017 quarter at -63.00%.
Average
-15.15%
Median
-2.99%
Minimum
-87.46%
Maximum
12.61%
Crescita Therapeutics Inc. (CTX.TO) ROE by Quarter and Year
Discovering the peaks and valleys of Crescita Therapeutics Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 64.65%
Maximum Annual ROE = 12.61%
Minimum Annual Increase = -3174.80%
Minimum Annual ROE = -87.46%
| Year | ROE | Change |
|---|---|---|
| 2025 | -0.59% | -96.60% |
| 2024 | -17.37% | 64.65% |
| 2023 | -10.55% | -358.23% |
| 2022 | 4.09% | -175.90% |
| 2021 | -5.38% | -3174.80% |
| 2020 | 0.18% | -98.01% |
| 2019 | 8.79% | -30.29% |
| 2018 | 12.61% | -114.41% |
| 2017 | -87.46% | 56.85% |
| 2016 | -55.76% | -112.15% |
Crescita Therapeutics Inc. (CTX.TO) Average ROE
How has CTX.TO ROE performed in the past?
The current ROE of Crescita Therapeutics Inc. (CTX.TO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-9.51%
5-year avg
-5.96%
10-year avg
-15.15%
Crescita Therapeutics Inc. (CTX.TO) ROE vs. Peers
How is CTX.TO’s ROE compared to its peers?
Crescita Therapeutics Inc.’s ROE is greater than Mydecine Innovations Group Inc. (-14.60%), greater than Delivra Health Brands Inc. (-9.77%), less than CLS Holdings USA, Inc. (3.09%), less than Lobe Sciences Ltd. (395.56%), greater than Captiva Verde Wellness Corp. (-81.17%), less than Ayurcann Holdings Corp. (244.07%), greater than Avant Brands Inc. (-48.61%), greater than Blueberries Medical Corp. (-167.41%), less than BetterLife Pharma Inc. (19.14%), greater than Glow Lifetech Corp. (-25.39%),
| Company | ROE | Market cap |
|---|---|---|
| -14.60% | $21.42M | |
| -9.77% | $4.38M | |
| 3.09% | $8.11M | |
| 395.56% | $17.39M | |
| -81.17% | $13.57M | |
| 244.07% | $1.95M | |
| -48.61% | $6.95M | |
| -167.41% | $4.95M | |
| 19.14% | $9.11M | |
| -25.39% | $9.06M |
Build a custom stock screener for Crescita Therapeutics Inc. (CTX.TO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Crescita Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Crescita Therapeutics Inc. (CTX.TO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Crescita Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Crescita Therapeutics Inc.'s ROE?
How is the ROE calculated for Crescita Therapeutics Inc. (CTX.TO)?
What is the highest ROE for Crescita Therapeutics Inc. (CTX.TO)?
What is the 3-year average ROE for Crescita Therapeutics Inc. (CTX.TO)?
What is the 5-year average ROE for Crescita Therapeutics Inc. (CTX.TO)?
How does the current ROE for Crescita Therapeutics Inc. (CTX.TO) compare to its historical average?